RTA Laboratuvarlari Biyolojik (RTALB) — Cash Flow Reinvestment Rate
RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow Reinvestment Rate of 5.26x as of June 2025, reinvesting TL110.45 Million (capex TL2.68 Million plus investments TL107.77 Million) from operating cash flow of TL20.98 Million. See RTALB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
RTA Laboratuvarlari Biyolojik Cash Flow Reinvestment Rate (2010–2023)
Historical reinvestment intensity for RTA Laboratuvarlari Biyolojik across 12 annual periods. For the full cash flow conversion analysis, see RTALB cash flow metrics.
Annual Cash Flow Reinvestment Rate for RTA Laboratuvarlari Biyolojik (2010–2023)
Year-by-year capital reinvestment analysis for RTA Laboratuvarlari Biyolojik. See RTALB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.33x | TL96.46 Million | TL72.41 Million | TL48.48 Million | ▲ +251.9% |
| 2021 | 0.38x | TL26.04 Million | TL68.78 Million | TL21.43 Million | ▼ -78.7% |
| 2020 | 1.78x | TL16.65 Million | TL9.37 Million | TL15.96 Million | ▼ -78.4% |
| 2019 | 8.21x | TL29.36 Million | TL3.58 Million | TL5.19 Million | ▼ -52.9% |
| 2017 | 17.43x | TL24.49 Million | TL1.41 Million | TL318.64K | ▲ +853.4% |
| 2016 | 1.83x | TL5.23 Million | TL2.86 Million | TL2.42 Million | ▲ +576.1% |
| 2015 | 0.27x | TL1.67 Million | TL6.18 Million | TL1.67 Million | ▲ +9.1% |
| 2014 | 0.25x | TL640.00K | TL2.58 Million | TL640.00K | ▼ -70.8% |
| 2013 | 0.85x | TL9.56 Million | TL11.26 Million | TL9.56 Million | ▼ -9.3% |
| 2012 | 0.94x | TL2.09 Million | TL2.24 Million | TL2.09 Million | ▲ +349.9% |
| 2011 | 0.21x | TL335.00K | TL1.61 Million | TL335.00K | ▲ +6.7% |
| 2010 | 0.19x | TL541.00K | TL2.78 Million | TL541.00K | — |